IFA current information

Here you’ll be informed about notifications and get to read excerpt from our letter to the suppliers:

12/27/2023 | Extensions of IFA Database as of 01 February 2024

"... on publication date 01 February 2024 the IFA database will receive new and modified data fields for medicinal products. Relevant information on the changes and the need to notify your products accordingly can be found here: Information for medicinal products

Please find attached a current EAD file with the medicinal products of your product range. Please check the product data if corrections and additions are required and submit the updated table to ead@ifaffm.de.

Please find more detailed information regarding to the database changes in our IFA Guidelines for Notifying Product and Address data.

We thank you in advance for checking and completing your data.

For any questions, please contact us at ifa@ifaffm.de. ..."

less

11/21/2023 | First publications of PZN – now available in IFA portal

"... over the past few months, we have enjoyed a steadily growing number of users of the IFA portal. In the meantime, we have been working on its further development and today we have reached the next milestone. We are pleased to offer you the possibility to order first publications of your products!

During the development, it was important to us that you can notify your first publications conveniently and time saving, and that you can focus on the essentials by using templates and pre-settings.

Therefore, we have added the following features to the IFA portal for you:

  • Assisted capture of first publications of PZN
  • Selection of existing PZN pre-allocations for publication
  • Use of already published products as a template
  • Duplicating a first publication already entered in the notification order
  • Pre-setting of default values analogous to the IFA excel order files
  • Pre-setting of non-relevant data fields depending on the selected product category

To help you get started, the annex provides a brief explanation on how to capture first publications in the IFA portal. However this is only available in German unfortunately.

In the coming months, we will focus on providing functions for capturing and editing PZN pre-allocations in order to continuously develop the IFA portal and provide you with a user-friendly and convenient platform for your notification orders. Please note that the IFA portal is currently only available in German.

You do not have access to the IFA portal yet? Click here for Request your user ID.

If you have any questions, please send them to ifa@ifaffm.de. We will be glad to help you. ..."

less

10/02/2023 | IFA pharmaceutical form extension as of 1st October 2023

"... Due to applications to extend the IFA pharmaceutical form, IFA GmbH has expanded the IFA pharmaceutical form table as of 1st October 2023. The extension of the pharmaceutical form table may lead to changes in article-identifying characteristics with possible effects on the reference price allocations (Festbeträge) or aut idem. Therefore, the extension is made in accordance with a procedure agreed with the expert groups, with a lead time before first publication.

If you carry medicinal products in your range, you are obliged to report the pharmaceutical form in line with section 3 of the SPC according to § 131 paragraph 4 SGB V (German Social Code Book 5).

The following new pharmaceutical forms are available from 1st October 2023 for first publication on 1st October 2024:

  • Dispersion for injection/infusion (IID)
  • Intravesical solution (LIV)

If any corrections need to be made in the data field pharmaceutical form in connection with the current pharmaceutical form extension, please let us know. With correct data notification, you make a significant contribution to ensure that data users can properly dispense and invoice your products. Please use Auftragstabelle für Änderungen an IFA-Darreichungsformen and send it to us in the case of changes to pharmaceutical data with the current SPC. In this exceptional case, we will process your notification free of charge until the specified publication date while maintaining the PZN. After a successful assessment we will change the pharmaceutical form and publish it for the first time on 1st October 2024.

The e-mail address for your change notifications is ifa@ifaffm.de.

Our website holds the Auftragstabelle für Änderungen an IFA-Darreichungsformen and Richtlinie zu den IFA-Darreichungsformen ready for you.

If you have any questions, please send them to ifa@ifaffm.de. We will be glad to help you...."

 

less

07/31/2023 | Amendment to the Pharmaceutical Price Ordinance

"... as of 27.07.2023 Arzneimittelpreisverordnung has changed for prescription-only medicinal products. This change will be implemented at IFA GmbH on the next possible publication date, 01.09.2023.

Due to Arzneimittel-Lieferengpassbekämpfungs- und Versorgungsverbesserungsgesetzes (ALBVVG) the calculation of the Apothekeneinkaufspreis (AEP) and Apothekenverkaufspreis (AVP) changes as follows:

Abgabepreis des pharmazeutischen Unternehmers (APU)
+ 3.15 percent (max. 37.80 Euro)
+ 0.73 Euro
= Apothekeneinkaufspreis (AEP) 

AEP
+ 3 percent
+ 8.76 Euro
+ VAT
= AVP

The attached excel EAD file contains your company’s affected prescription-only medicinal products with the prices recalculated as of 01.09.2023. If you consider it is necessary to correct the prices reported, please send us the corrected list by Tuesday, 15.08.2023 to ead@ifaffm.de exclusively. Thank you in advance.

If you have any questions, please send them to ifa@ifaffm.de. We will be glad to help you. ..."

less

05/15/2023 | Your IFA notifications - timely and efficient

"... recently we informed you in a German-speaking mailing about the new possibilities to comfortably view and edit your published product data via IFA portal. In the course of this innovation process, we would like to inform you that orders via order forms in PDF format will still be possible until 30.06.2023.

This means that EAD (Electronic Order Data Processing), the IFA order tables and the IFA portal (currently available in German) will be available to you as ways of placing orders from 01.07.2023:

PZN pre-allocations prior to market launch
Excel order file A

First publication of products
Excel order file B1 Medicinal product
Excel order file B3 Medical devices
Excel order file B2 other pharmacy-typical products

Changes and additions
IFA-Portal (platform and support currently only available in German)
EAD files (Electronic Order Data Processing)
Excel order file C also for deletions of product data

Change of address data
Excel order file D

When using the order tables, please always use the current version from the IFA homepage.

If you have any questions, please send them to ifa@ifaffm.de. ..."

less

03/20/2023 | Extensions of IFA database

"... due to changes in legislation and the extension of the pharmaceutical form table, there are new and amended data fields in IFA database on the following publication dates:

For publication date of 15.04.2023:

1. New Data field: APU § 130a Abs. 3c Satz 6 SGB V vereinbart – sales price of the pharmaceutical entrepreneur Section 130a (3c) clause 6 German Social Code Book V (SGB V) agreed

2. New Data field: Datum, ab dem der vereinbarte APU § 130a Abs. 3c Satz 6 SGB V gilt – Date from which the agreed APU Section 130a (3c) clause 6 German Social Code Book V (SGB V) applies

3. Expanded and renamed data field: TAMG Tierarzneimittelgesetz – TAMG Veterinary medicinal products Act (former: Tierarzneimittel – Veterinary medicinal product)

For publication date of 01.07.2023:

4. New IFA pharmaceutical form

 

Below you will find information about the data fields and which entries IFA has made for you. You will find further information in the IFA-Guidelines for Notifying Product and Address data.

To 1: APU § 130a Abs. 3c Satz 6 SGB V vereinbart – sales price of the pharmaceutical entrepreneur Section 130a (3c) clause 6 German Social Code Book V (SGB V) agreed:

GKV-Finanzstabilisierungsgesetz (GKV-FinStG) contains Section 130a (3c) SGB V. Accordingly, pharmaceutical entrepreneurs may apply for an exemption from the extended price moratorium pursuant to Section 130a (3a) clause 4 or 5 SGB V under certain conditions. In the case of affected medicinal products, it must be stated whether sales price of the pharmaceutical entrepreneur has been agreed for them in accordance with Section 130a (3c) clause 6 SGB V.

  • IFA has preset this data field for you with the value 0= 
  • If you have agreed on an APU in accordance with Section130a (3c) clause 6 of the German Social Code, Book V, please arrange for the correction to value 1 = yes in one of the following ways:
    Either in a currently requested EAD file to ead@ifaffm.de or in the IFA reporting portal or with the IFA order table C - Changes to ifa@ifaffm.de.
  • If you have not agreed on an APU in accordance with Section 130a (3c) clause 6 of SGBV, there is no need for you to take any action.

To 2: Datum, ab dem der vereinbarte APU § 130a Abs. 3c Satz 6 SGB V gilt – Date from which the agreed APU Section 130a (3c) clause 6 German Social Code Book V (SGB V) applies

For medicinal products for which a new sales price has been agreed by the pharmaceutical entrepreneur with the GKV-Spitzenverband on the basis of Section130a (3c) clause 6 SGB V, the date from which this price applies must be stated.

  • IFA does not preset any data in this data field.
  • If you have agreed on an APU in accordance with Section130a (3c) clause 6 of the German Social Code, Book V, please submit the corresponding date by using one of the following methods:
    Either in a currently requested EAD file to ead@ifaffm.de or in the IFA reporting portal or with the IFA order table C - Changes to ifa@ifaffm.de.
  • If you have not agreed on an APU in accordance with Section 130a (3c) clause 6 of SGBV, there is no need for you to take any action.

To 3: TAMG Tierarzneimittelgesetz – TAMG Veterinary medicinal products Act

This data field is the renamed data field Veterinary Medicinal Product. It must be indicated whether the product is subject to the Veterinary Medicinal Products Act (TAMG) as a veterinary medicinal product (value 1) or as a veterinary medical technology device subject to authorization (VMTP; value 2). The regulations of the TAMG apply to both types of products. Their approval must be evidenced by a proof of marketing authorisation, e.g. from Federal Office of Consumer Protection and Food Safety (BVL).

  • IFA takes over the previous identification of the data field Tierarzneimittel – Veterinary medicinal product.
  • If you have a product in your assortment that is a VMTP, please initiate a data change of this PZN in one of the following ways:
    Either in the IFA reporting portal or with the IFA order table C - Changes to ifa@ifaffm.de and provide the proof of marketing authorisation.
  • If you do not have VMTP in your assortment, there is no need for you to take action.

To 4: New IFA pharmaceutical form

Furthermore, we would like to inform you that the IFA pharmaceutical form table will be extended by the following value as of 01.04.2023 for a first publication on 01.07.2023:

  • Dispersion for injection (Injektionsdispersion IJD)

Details on the extension of the pharmaceutical form table can be found in the guideline IFA-Richtlinien zu Darreichungsformen.

We kindly ask you to always use the updated and most recent notification order documents.

If you have any questions, please send them to ifa@ifaffm.de. We will be glad to help you ...."

less

Document Finder
Table of content
×